Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma
The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital...
Saved in:
Published in | Cancer management and research Vol. 12; pp. 8275 - 8285 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2020
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC).
From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations.
Low CD8+ TIL counts were associated with advanced tumor stages (
=0.034), and low CD8/CD3 ratios were associated with perineural invasion (
=0.043). Both parameters were also associated with increased tumor depths (
=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively).
The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival. |
---|---|
AbstractList | Purpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC). Patients and Methods: From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations. Results: Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively). Conclusion: The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival. Purpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC). Patients and Methods: From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations. Results: Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively). Conclusion: The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival. Keywords: oral cavity, squamous cell carcinoma, oral cancer, SCC, tumor-infiltrating lymphocyte, TIL The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC). From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations. Low CD8+ TIL counts were associated with advanced tumor stages ( =0.034), and low CD8/CD3 ratios were associated with perineural invasion ( =0.043). Both parameters were also associated with increased tumor depths ( =0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively). The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival. Yenlin Huang,1,2 Chieh Lin,3 Huang-Kai Kao,2,4 Shao-Yu Hung,4 Hung-Ju Ko,2 Yu-Chen Huang,5 Yu-Liang Chang,5 Kai-Ping Chang2,6 1Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 2College of Medicine, Chang Gung University, Taoyuan, Taiwan; 3Department of Nuclear Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 4Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 5Department of Oral & Maxillofacial Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 6Department of Otolaryngology - Head & Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, TaiwanCorrespondence: Kai-Ping ChangDepartment of Otolaryngology - Head & Neck Surgery, Chang Gung Memorial Hospital, No. 5, Fu-Hsing Street, Kwei-Shan, Taoyuan 333005, TaiwanTel +886-3-3281200 ext 3972Fax +886-3-3979361Email dr.kpchang@gmail.comPurpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC).Patients and Methods: From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations.Results: Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively).Conclusion: The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival.Keywords: oral cavity, squamous cell carcinoma, oral cancer, SCC, tumor-infiltrating lymphocyte, TIL The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC).PURPOSEThe presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8+/CD3+ TILs in tongue squamous cell carcinoma (TSCC).From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations.PATIENTS AND METHODSFrom 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations.Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively).RESULTSLow CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively).The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival.CONCLUSIONThe use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival. |
Audience | Academic |
Author | Chang, Kai-Ping Huang, Yenlin Huang, Yu-Chen Hung, Shao-Yu Kao, Huang-Kai Chang, Yu-Liang Lin, Chieh Ko, Hung-Ju |
Author_xml | – sequence: 1 givenname: Yenlin orcidid: 0000-0002-9647-1135 surname: Huang fullname: Huang, Yenlin – sequence: 2 givenname: Chieh surname: Lin fullname: Lin, Chieh – sequence: 3 givenname: Huang-Kai surname: Kao fullname: Kao, Huang-Kai – sequence: 4 givenname: Shao-Yu surname: Hung fullname: Hung, Shao-Yu – sequence: 5 givenname: Hung-Ju surname: Ko fullname: Ko, Hung-Ju – sequence: 6 givenname: Yu-Chen surname: Huang fullname: Huang, Yu-Chen – sequence: 7 givenname: Yu-Liang surname: Chang fullname: Chang, Yu-Liang – sequence: 8 givenname: Kai-Ping orcidid: 0000-0003-1777-9578 surname: Chang fullname: Chang, Kai-Ping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32982423$$D View this record in MEDLINE/PubMed |
BookMark | eNptUltr2zAYNaNjvWxvex6CvQy6ZNbNll4GwW23QMZgzZ6FrIujYEupZQ_y76dcujWl6EEf0jnn43zfuczOfPAmy97DfIogKb9UP2a_pveIUgaLV9kFhCWfQIzQ2ZP6PLuMcZ3nBYeYvMnOMeIMEYQvstWNa9wgWzDvZGPAzMt2G10EwYLqhl0D6XUq8DVYjl3oJ3NvXTv0cnC-AYttt1kFtR1MBM6DZfDNaMD9wyi7MEZQmbYFleyV86GTb7PXVrbRvDveV9nvu9tl9X2y-PltXs0WE0UJHSaWG4LrnOa1Li2ra64lYYQpCWtKMYM1qmurJGUMGYuYgoVBRlsoGcUKaomvsvlBVwe5FpvedbLfiiCd2D-EvhGyH5xqjcC6LC3RJFEJ0bxgxDBqTU6tpQrXRdL6etDajHVntDI-WW9PRE9_vFuJJvwRJeF5jnkS-HQU6MPDaOIgOhdVmov0Jo1IIEIKzjhju14fn0HXYezTOvYoXBQEUfgf1chkwHkbUl-1ExWzAvMclXjfdvoCKh1tOqdSfNISzSnhw1Oj_xw-5iQB0AGg-hBjb6xQKTWDCzvfrhUwF7swil0YxTGMifT5GelR90X4X5LF3c0 |
CitedBy_id | crossref_primary_10_3389_fonc_2021_616629 crossref_primary_10_1002_btm2_10628 crossref_primary_10_3390_cancers14061558 crossref_primary_10_3390_cancers16142514 crossref_primary_10_1016_j_biopha_2024_117544 crossref_primary_10_1016_j_ejca_2021_06_011 crossref_primary_10_1016_j_eclinm_2021_101134 crossref_primary_10_3389_fimmu_2021_596646 crossref_primary_10_1016_j_prp_2021_153473 crossref_primary_10_1002_advs_202202702 crossref_primary_10_30683_1929_2279_2023_12_6 crossref_primary_10_1016_j_jsbmb_2024_106462 crossref_primary_10_3389_fimmu_2022_997806 crossref_primary_10_7759_cureus_58748 crossref_primary_10_1111_jop_13525 crossref_primary_10_1016_j_anndiagpath_2024_152387 |
Cites_doi | 10.1016/j.ijrobp.2006.06.026 10.1186/s12885-017-3317-2 10.1097/PAI.0000000000000466 10.1097/PAS.0b013e3181d95c37 10.1038/bjc.2015.277 10.1111/jop.12605 10.1016/j.oraloncology.2014.09.006 10.1016/S0140-6736(18)30789-X 10.1016/0002-9610(74)90275-x 10.1002/lary.27413 10.1111/jop.12698 10.1038/s41591-018-0014-x 10.1002/cam4.1889 10.1038/modpathol.2017.156 10.1186/s13014-018-1099-6 10.1200/jco.2010.30.5037 10.1200/JCO.2015.63.0970 10.18632/oncotarget.17901 10.1016/j.ctro.2019.05.001 10.1002/(sici)1097-0142(19960401)77:7<1303::Aid-cncr12>3.0.Co;2-5 10.1126/scitranslmed.aad6352 10.6696/IJHNS.2017.0103.05 10.1016/j.oraloncology.2009.05.640 10.1002/path.4287 10.1016/j.oraloncology.2011.08.007 10.1007/s11912-017-0624-3 |
ContentType | Journal Article |
Copyright | 2020 Huang et al. COPYRIGHT 2020 Dove Medical Press Limited 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 Huang et al. 2020 Huang et al. |
Copyright_xml | – notice: 2020 Huang et al. – notice: COPYRIGHT 2020 Dove Medical Press Limited – notice: 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 Huang et al. 2020 Huang et al. |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.2147/CMAR.S255816 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Huang et al |
EISSN | 1179-1322 |
EndPage | 8285 |
ExternalDocumentID | oai_doaj_org_article_3d77f4d485344d9684e85fe05ff5c3b6 PMC7490039 A639027339 32982423 10_2147_CMAR_S255816 |
Genre | Journal Article |
GeographicLocations | Taiwan Germany |
GeographicLocations_xml | – name: Taiwan – name: Germany |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29B 2WC 53G 5VS 7X7 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IPNFZ ITC KQ8 M2O M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL TR2 UKHRP VDV NPM PMFND 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c545t-f9e43b050bd7f8bb9da4848ca1b55381b2bbfca5882ef28c16e2edf1a853c1da3 |
IEDL.DBID | 7X7 |
ISSN | 1179-1322 |
IngestDate | Wed Aug 27 01:26:40 EDT 2025 Thu Aug 21 14:04:44 EDT 2025 Fri Jul 11 03:41:40 EDT 2025 Sun Jun 29 13:43:37 EDT 2025 Tue Jun 17 20:57:35 EDT 2025 Tue Jun 10 20:46:17 EDT 2025 Thu Jan 02 22:54:32 EST 2025 Thu Apr 24 23:09:35 EDT 2025 Tue Jul 01 02:41:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | oral cavity tumor-infiltrating lymphocyte SCC TIL oral cancer squamous cell carcinoma |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 2020 Huang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c545t-f9e43b050bd7f8bb9da4848ca1b55381b2bbfca5882ef28c16e2edf1a853c1da3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1777-9578 0000-0002-9647-1135 |
OpenAccessLink | https://www.proquest.com/docview/2443664251?pq-origsite=%requestingapplication% |
PMID | 32982423 |
PQID | 2443664251 |
PQPubID | 3933196 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3d77f4d485344d9684e85fe05ff5c3b6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7490039 proquest_miscellaneous_2446989886 proquest_journals_2443664251 gale_infotracmisc_A639027339 gale_infotracacademiconefile_A639027339 pubmed_primary_32982423 crossref_citationtrail_10_2147_CMAR_S255816 crossref_primary_10_2147_CMAR_S255816 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Cancer management and research |
PublicationTitleAlternate | Cancer Manag Res |
PublicationYear | 2020 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
References | Brandwein-Gensler (ref18) 2010; 34 Fang (ref6) 2017; 17 De Paz (ref2) 2017; 19 Fan (ref4) 2007; 67 Shimizu (ref7) 2019; 8 Oguejiofor (ref20) 2015; 113 Clemente (ref25) 1996; 77 Cho (ref26) 2011; 47 Mahmoud (ref10) 2011; 29 Poropatich (ref23) 2017; 46 Distel (ref19) 2009; 45 Zhou (ref21) 2018; 47 Mlecnik (ref13) 2016; 8 Brambilla (ref9) 2016; 34 Wolf (ref8) 2015; 51 Hansen (ref15) 1974; 128 Chen (ref5) 2018; 13 Binnewies (ref14) 2018; 24 Lee (ref12) 2019; 17 Taube (ref16) 2018; 31 Pages (ref11) 2018; 391 Galon (ref17) 2014; 232 De Paz (ref3) 2019; 129 Hsu (ref1) 2017; 1 Khoury (ref24) 2018; 26 Lechner (ref22) 2017; 8 |
References_xml | – volume: 67 start-page: 453 year: 2007 ident: ref4 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2006.06.026 – volume: 17 start-page: 375 year: 2017 ident: ref6 publication-title: BMC Cancer doi: 10.1186/s12885-017-3317-2 – volume: 26 start-page: 523 year: 2018 ident: ref24 publication-title: Appl Immunohistochem Mol Morphol doi: 10.1097/PAI.0000000000000466 – volume: 34 start-page: 676 year: 2010 ident: ref18 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e3181d95c37 – volume: 113 start-page: 886 year: 2015 ident: ref20 publication-title: Br J Cancer doi: 10.1038/bjc.2015.277 – volume: 46 start-page: 972 year: 2017 ident: ref23 publication-title: J Oral Pathol Med doi: 10.1111/jop.12605 – volume: 51 start-page: 90 year: 2015 ident: ref8 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2014.09.006 – volume: 391 start-page: 2128 year: 2018 ident: ref11 publication-title: Lancet doi: 10.1016/S0140-6736(18)30789-X – volume: 128 start-page: 557 year: 1974 ident: ref15 publication-title: Am J Surg doi: 10.1016/0002-9610(74)90275-x – volume: 129 start-page: 1123 year: 2019 ident: ref3 publication-title: Laryngoscope doi: 10.1002/lary.27413 – volume: 47 start-page: 359 year: 2018 ident: ref21 publication-title: J Oral Pathol Med doi: 10.1111/jop.12698 – volume: 24 start-page: 541 year: 2018 ident: ref14 publication-title: Nat Med doi: 10.1038/s41591-018-0014-x – volume: 8 start-page: 80 year: 2019 ident: ref7 publication-title: Cancer Med doi: 10.1002/cam4.1889 – volume: 31 start-page: 214 year: 2018 ident: ref16 publication-title: Mod Pathol doi: 10.1038/modpathol.2017.156 – volume: 13 start-page: 157 year: 2018 ident: ref5 publication-title: Radiat Oncol doi: 10.1186/s13014-018-1099-6 – volume: 29 start-page: 1949 year: 2011 ident: ref10 publication-title: J Clin Oncol doi: 10.1200/jco.2010.30.5037 – volume: 34 start-page: 1223 year: 2016 ident: ref9 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.63.0970 – volume: 8 start-page: 44418 year: 2017 ident: ref22 publication-title: Oncotarget doi: 10.18632/oncotarget.17901 – volume: 17 year: 2019 ident: ref12 publication-title: Clin Transl Radiat Oncol doi: 10.1016/j.ctro.2019.05.001 – volume: 77 start-page: 1303 year: 1996 ident: ref25 publication-title: Cancer doi: 10.1002/(sici)1097-0142(19960401)77:7<1303::Aid-cncr12>3.0.Co;2-5 – volume: 8 start-page: 327ra326 year: 2016 ident: ref13 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aad6352 – volume: 1 start-page: 180 year: 2017 ident: ref1 publication-title: Int J Head Neck Sci doi: 10.6696/IJHNS.2017.0103.05 – volume: 45 start-page: e167 year: 2009 ident: ref19 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2009.05.640 – volume: 232 start-page: 199 year: 2014 ident: ref17 publication-title: J Pathol doi: 10.1002/path.4287 – volume: 47 start-page: 1148 year: 2011 ident: ref26 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2011.08.007 – volume: 19 start-page: 65 year: 2017 ident: ref2 publication-title: Curr Oncol Rep doi: 10.1007/s11912-017-0624-3 |
SSID | ssj0069134 |
Score | 2.251783 |
Snippet | The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However,... Purpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors.... Yenlin Huang,1,2 Chieh Lin,3 Huang-Kai Kao,2,4 Shao-Yu Hung,4 Hung-Ju Ko,2 Yu-Chen Huang,5 Yu-Liang Chang,5 Kai-Ping Chang2,6 1Department of Anatomic... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 8275 |
SubjectTerms | Cancer therapies Chemotherapy Head & neck cancer Immunohistochemistry Lymphocytes Medical prognosis Medical research Oral cancer oral cavity Original Research Patients Radiation therapy scc Software Squamous cell carcinoma til tumor-infiltrating lymphocyte Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQD4gLojxTCjISiEO0NLu2d73HsKVqEeFAU6k3y880UuKlJTn03zOzjygrhLhwi-JZyZ4Zz3zj9X5DyHvvfcqE9UnuM51APnZJKYVIRLAATpnwYoIfCs--5-dX_Ou1uN5r9YV3wlp64FZxJ8wVReCOw4OcuzKX3EsR_ESEICwzDdk25Ly-mGpjcN6_TwZ3S7Deaq-8Y0-ek2o2_fHpEpC0xB7ne8mo4ez_MzLvpabhtcm9PHT2hDzuACSdthM_JA98fEoezrpX5M_IzelygY1A6MUaQgXtSUdoHWh1KsdURwc_2JjOt-v6LrmIYblqqHPjgn67B9vW9h7gJ11GOq_jYuvp5e1W4wEBrfxqRStsPhTrtX5Ors6-zKvzpGunkFiASZsklJ4zMxET44ogjSmd5pJLq1MjIOylJjMmWC0Ac_uQSZuC-bwLqQbV29Rp9oIcxDr6V4RmyEbpoXoxJeM2MxAxhbNYPHkAiGU6IuNer8p2XOPY8mKloOZAKyi0guqsMCIfdtI_W46Nv8h9RhPtZJAZu_kD_EV1_qL-5S8j8hENrHD_wpSs7j5DgIUhE5aaAmRDjh9WjsjxQBL2nR0O9y6iun3_SwFYYjmUdAJU8G43jE_iXbbowVgo03TtlDCXl61H7ZbEslIiwh2RYuBrgzUPR-LypmEFLzgeSpdH_0NJr8mjDM8VmqOmY3Kwudv6NwC-NuZts89-A3z0KS8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLXGkBAviO91DGQkEA9VRhPbifOAUMmYNkR5YK20tyj-6iqlDutaif577k2TaNGAtyq-qWyfa_tc2zmXkHfW2pAJbYPYRkUA67EJUilEIJwGcsqEFSP8UHjyIz6b8W-X4nKPtNlGmw68-Wtoh_mkZqvy-Pf19jMM-E94jTnkycdsMv55fAHcWIbxPXIf1qQEcxlMeHeeEOP58u7a-503egtSrdt_d3a-tTz1r07eWotOH5NHDYmk4x3qT8ie9U_Jg0lzTP6MXJ0s5pgMhJ4vYbqgrfAIrRzNTuSQFt7ADzak082yWgXn3i3KWj7Xz-n3LeBb6S1QULrwdFr5-cbSi-tNgZsENLNlSTNMQOSrZfGczE6_TrOzoEmpEGigSuvApZYzNRIjZRInlUpNwSWXugiVgKkvVJFSThcCeLd1kdQhQGiNCwvATYemYC_Ivq-8PSA0QkVKCxGMShnXkYJZUxiNAZQFkpiGAzJs-zXXjd44pr0oc4g7EIUcUcgbFAbkfWf9a6ez8Q-7LwhRZ4Pq2PWDajXPm8GWM5MkjhsOlebcpLHkVgpnR8I5oZmCP_mAAOfoVVAlXTSfIkDDUA0rHwNtQ50flg7IUc8Sxp7uF7cukreumwNhYjGEdQK64G1XjG_ifTZvASy0qTN3SqjLy51HdU1iUSqR5Q5I0vO1Xpv7JX5xVSuDJxw3ptPD_1frFXkY4a5BvZF0RPbXq419DdRqrd7Uo-YP8WMhHQ priority: 102 providerName: Scholars Portal |
Title | Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32982423 https://www.proquest.com/docview/2443664251 https://www.proquest.com/docview/2446989886 https://pubmed.ncbi.nlm.nih.gov/PMC7490039 https://doaj.org/article/3d77f4d485344d9684e85fe05ff5c3b6 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBZbC2Mvo7vWaxc02NhD8BpbUiw_jTRt146ljDaFvBnrlgYSuU2Th_77neMoWczYXoyJ5CD53D4dyd8h5JO1NmFC27hr0zKGeGziXAoRC6cBnDJhRQc_FB5cds9v-I-RGIWE20M4Vrn2ibWjNpXGHPkRhCHWBbAskm939zFWjcLd1VBC4ynZReoy1OpstFlwdXFXeXXYHavxHPUHvauv14ChJVY33wpDNVv_3z55Kyg1D0xuRaCzPfIiQEfaW8n6JXli_SvybBA2x1-T25PJGEuA0IsZOAm6phuhlaP9E9mmpTdww9p0uJxV8_jCu8m0Js31Y_rzEaRa6UcAnnTi6bDy46Wl1_fLElMDtG-nU9rHskO-mpVvyM3Z6bB_HodCCrEGgLSIXW45Ux3RUSZzUqnclFxyqctECXB4iUqVcroUgLatS6VOQHDWuKQEaenElOwt2fGVt_uEpshDaWHdonLGdarAVwqjcdlkARrmSUTa6_da6MAyjsUupgWsNlAKBUqhCFKIyOdN77sVu8Y_-h2jiDZ9kBO7_qGaj4tgYgUzWea44TBozk3eldxK4WxHOCc0U_AnX1DABVouDEmX4QMEmBhyYBU9AGvI7sPyiBw2eoLF6WbzWkWKYPEPxR_9jMjHTTM-iafYvAVhYZ-6XqeEsbxbadRmSizNJWLbiGQNXWvMudniJ7c1H3jGMR2dv___sA7I8xRzBXX66JDsLOZL-wEA1UK1aqtpkd3j08tfV606LQHX76MErgMufwM-hSM7 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxJtAgUWi4hCZ2t7d2D4gFBKqhCY90FTKbet9pZESu00TofwpfiMzjh1iIbj1FmXH1q7n9c3s7gwhH6y1ARPaei0bph74Y-MlsRCecBrAKRNW-HhReHja6p3z72Mx3iO_qrsweKyysomFoTa5xhz5Ebgh1gKwLIIvV9cedo3C3dWqhcZGLE7s-ieEbDef-13g72EYHn8bdXpe2VXA04AWlp5LLGfKF74ykYuVSkzKYx7rNFACtD9QoVJOpwKgp3VhrANYhTUuSGHqOjApg_feIXfB8foY7EXjbYDXwl3szeF67P5z1Bm2f3w6A8weYzf1HbdXdAf42wfsOMH6Ac0dj3f8iDwsoSptb2TrMdmz2RNyb1huxj8ll93pBFuO0P4cjBKtypvQ3NFON27SNDPwgzXpaDXPF14_c9NZUaQ3m9DBGqQo12sAunSa0VGeTVaWnl2vUkxF0I6dzWgH2xxl-Tx9Rs5v5RM_J_tZntmXhIZY99JCnKQSxnWowDYLozFMswBFk6BBmtV3lbqsao7NNWYSohvkgkQuyJILDXK4pb7aVPP4B91XZNGWBmtwF3_ki4ksVVoyE0WOGw6T5twkrZjbWDjrC-eEZgpe8hEZLNFSwJR0Wl54gIVhzS3ZBnCI1YRY0iAHNUrQcF0frkRElhbmRv7RhwZ5vx3GJ_HUXGaBWUhT9AeNYS4vNhK1XRILkxixdINENVmrrbk-kk0vi_rjEcf0d_Lq_9N6R-73RsOBHPRPT16TByHmKYrU1QHZXy5W9g2AuaV6W2gQJRe3rbK_AcPjXbQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9pAEF6lRIp6qfqu27TdSo16QC7Y3sXrQ1URCApNQFFCpNwc74sggZ0QUMVf66_rjLEpVtXeckPs2trxvL6Z3Z0h5LMxxgu4Mm7L-IkL_li7keDc5VYBOA244U28KDwYto4v2Y8rfrVDfpV3YfBYZWkTc0OtM4U58ga4oaAFYJl7DVscizjr9r7f3rnYQQp3Wst2GmsROTGrnxC-3X_rd4HXB77fOxp1jt2iw4CrADksXBsZFsgmb0odWiFlpBMmmFCJJzlYAk_6UlqVcIChxvpCeUCR0dZLgAzl6SSA9z4iuyFGRTWye3g0PDsv_UAL97TXR-2xF1CjM2iff70ABC-wt_qWE8x7BfztEbZcYvW45pb_6z0lTwrgSttrSXtGdkz6nOwNiq35F-SmOxljAxLan4GJomWxE5pZ2umKOk1SDT-COh0tZ9nc7ad2Ms1L9qZjeroCmcrUCmAvnaR0lKXjpaEXd8sEExO0Y6ZT2sGmR2k2S16Sywf5yK9ILc1S84ZQH6tgGoiaZBQw5Uuw1FwrDNoMANPIc0i9_K6xKmqcY6uNaQyxDnIhRi7EBRcccrCZfbuu7fGPeYfIos0crMid_5HNx3Gh4HGgw9AyzWDRjOmoJZgR3Jomt5arQMJLviCDY7QbsCSVFNcfgDCswBW3ASpibaEgcsh-ZSbou6oOlyISF_bmPv6jHQ75tBnGJ_EMXWqAWTgn7xYqYC2v1xK1ISnwI4HI2iFhRdYqNFdH0slNXo08ZJgMj97-f1kfyR6oa3zaH568I499TFrkeax9UlvMl-Y9ILuF_FCoECXXD621vwHzK2NP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Digital+Image+Analysis+of+CD8%2B+and+CD3%2B+Tumor-Infiltrating+Lymphocytes+in+Tongue+Squamous+Cell+Carcinoma&rft.jtitle=Cancer+management+and+research&rft.au=Huang%2C+Yenlin&rft.au=Lin%2C+Chieh&rft.au=Huang-Kai%2C+Kao&rft.au=Shao-Yu%2C+Hung&rft.date=2020-01-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=1179-1322&rft.volume=12&rft.spage=8275&rft_id=info:doi/10.2147%2FCMAR.S255816&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1322&client=summon |